Zentalis Pharmaceuticals Inc. (NASDAQ:ZNTL) traded at $25.21 at last check on Wednesday, 04/27/2022, made an upward move of 15.43% on its previous day’s price.
Looking at the stock we see that its previous close was $21.84 with the day’s price range being $21.18 – $24.00. In terms of its 52-week price range, ZNTL has a high of $87.19 and a low of $21.18. The company’s stock has lost about -52.70% over that past 30 days.
Zentalis Pharmaceuticals Inc. has a market cap of $1.08 billion and is expected to release its quarterly earnings report on Mar 23, 2022 – Mar 28, 2022. Estimates by analysts give the company expected earnings per share (EPS) of -$1.32, with the EPS growth for the year raised at -$3.99 for 2021 and -$6.28 for next year. These figures represent 4.80% and -57.40% growth in EPS for the two years respectively.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the ZNTL stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is -27.61% off its SMA20 and -40.90% from its 50-day simple moving average. The RSI (14) is pointing at 33.64 while the volatility over the past week is 8.49% and jumps to 11.01% over the past one month. The average price target for the stock over the next 12 months is $85.70, with the estimates having a low of $67.00 and a high of $120.00. These price ends are -165.77% and -376.0% off the today’s price level respectively, although investors could be excited at the prospect of a -215.35% if the ZNTL share price touches on the median price of $79.50.
Let’s briefly compare Zentalis Pharmaceuticals Inc. (ZNTL) stock to its peers. We find that today’s price change of 15.43% and -64.26% over the past 12 months for ZNTL. Another of its peers Rogers Corporation (ROG) has gained 0.06% today, and was 40.47% up over the past year, while AstraZeneca PLC (AZN) is also up 1.48% yet, while its price remains in the green at 24.23% over the same period. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 0.40% and 0.24%, respectively, in early deals.
Coming back to Zentalis Pharmaceuticals Inc. (NASDAQ:ZNTL), we note that the average 3-month trading volume was 541.91K, while that of the preceding 10-day period stands at 0.77 million. Current shares outstanding are 45.00 million.
The insiders hold 5.70% of the company’s shares while institutions hold 96.80%. The data shows that short shares as of Feb 14, 2022, stood at 3.64 million at a short ratio of 11.66. This represents a 8.01% short interest in shares outstanding on Feb 14, 2022. Shares short rose in February from the previous month at 3.15 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -74.02% down in year-to-date price movement.